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Figure 6. Models of two truncated versions and a truncated and cyclic version of Peptide 1, 
obtained through the PEP-FOLD server. 
Cobratoxins target and inhibit the nicotinic acetylcholine receptors (nAChRs), 
thus efficient anti-cobratoxins must block this interaction.  
Peptide P1 was identified by phage display selection. 
According to docking studies Peptide 1 binds to the same α-CTX 
residues that are involved in the interaction with nAChRs. 
More than 5.5 million people per year are victims of snake envenomation, resulting in 125,000 deaths and 400,000 
amputations worldwide [1],[2]. Antivenoms are still produced by animal immunization procedures, and they are 
associated with a high risk of severe adverse reactions. Alternatively, synthetic peptides may open the possibility for new 
therapies with better efficacy and safety. Here, we report the discovery and optimization of a synthetic peptide directed 
against α-cobratoxin (α-CTX), the most toxic component of Monocled cobra (Naja kaouthia) [3].  
Figure 2. A) Crystallized structure of 5 α-CTX molecules (shown in blue, interaction regions in 
yellow) bound to the pentameric nAChR (in dark red) (PDB: 1YI5). B) Schematic overview of 
the physiological mechanism: α-CTX inhibits transmission of post-synaptic signals.   
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Figure 3. A) ELISA tests of panning rounds coupled to next generation sequencing lead to the 
discovery of Peptide 1. A tridimensional model of the peptide was obtained by the PEP-FOLD 
server [4]. 
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Figure 5. A) A tridimensional model of the interaction between Peptide 1 and α-CTX was 
obtained using the CABS-dock web server [5]. Peptide 1 binds to the II loop of α-CTX (shown 
in yellow), which is also involved in the interaction with nAChRs residues.  
Truncated and cyclic versions of Peptide 1 are expected to show increased affinity 
and neutralization capacity.
 
Other elapid venoms are rich in α-neurotoxins structurally similar to α-CTX, thus 
Peptide 1 and its optimized versions may provide protection against the neurotoxic 
effects exerted by α-neurotoxins present in a broad range of venoms.
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Figure 1: Naja kaouthia
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Figure 4. A) The Kd between Peptide 1 and α-CTX was determined by Isothermal Titration 
Calorimetry (ITC). B) Neutralization capacity was confirmed by two electrode voltage clamp 
(TEVC) assays: measured ion currents through the nAChR in Xenopus laevis oocytes show that 
Peptide P1 prevents α-CTX from inhibiting the ion current.  
Peptide 1 binds to α-CTX and inhibits its interaction with nAChRs 
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